ABBOTT PARK, Ill., Jan. 26, 2021 /PRNewswire/ -- Abbott (NYSE: ABT) announced today it has received CE Mark for two new uses of its Panbio™ COVID-19 Ag Rapid Test Device for the detection of the ...

Abbott Laboratories ABT recently received the CE Mark for its Panbio COVID-19 Antigen Self-Test for sale directly to consumers. The test, which delivers results in a few minutes, can be used to detect ...

Abbott has received new COVID-19 diagnostic approvals in Europe for its rapid Panbio antigen test, clearing it for self-performed screening under supervision as well as widespread use by people who ...

Even as Abbott continues to anticipate a steep drop-off in its COVID-19 testing sales boom—and recently updated its financial projections for the year to reflect that—testing demand has yet to ...

In England, the government began providing residents with free, rapid COVID tests twice a week on April 9. The Abbott Panbio rapid test — manufactured in the U.S. and now being used in pharmacies ...

OTTAWA, Oct 6 (Reuters) - Canada said on Tuesday that it had signed a deal with Abbott (ABT.N), opens new tab to purchase up to 20.5 million Panbio COVID-19 antigen tests as Health Canada approved the ...

In a recent study posted to the Lancet preprint* server, researchers assessed the utility of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) rapid antigen testing (RAT) for patient triage ...

Just in time for mosquito season, the FDA has approved the first screening test for West Nile virus. The blood test, made by PanBio Limited of Australia, detects antibodies in patients with symptoms ...

Add Yahoo as a preferred source to see more of our stories on Google. FILE PHOTO: People wait in line at a coronavirus disease (COVID-19) testing facility in Toronto. OTTAWA (Reuters) - Canada said on ...

OTTAWA, Oct 6 (Reuters) - Canada said on Tuesday that it had signed a deal with Abbott Rapid Diagnostics to purchase up to 20.5 million Panbio COVID-19 Antigen rapid tests. Health Canada has also ...